Pages that link to "Q72079058"
Jump to navigation
Jump to search
The following pages link to The in vivo distribution of autologous human and murine lymphoid cells grown in T cell growth factor (TCGF): implications for the adoptive immunotherapy of tumors (Q72079058):
Displaying 50 items.
- Immunotherapy for cancer: the use of lymphokine activated killer (LAK) cells (Q24548127) (← links)
- Adoptive T cell therapy for cancer in the clinic (Q24680405) (← links)
- Cryoimmunologic antitumor effects enhanced by dendritic cells in osteosarcoma (Q33785368) (← links)
- Porins and lipopolysaccharide (LPS) from Salmonella typhimurium induce leucocyte transmigration through human endothelial cells in vitro (Q33864288) (← links)
- Cytokine-Induced Killer Cells As Pharmacological Tools for Cancer Immunotherapy (Q33875615) (← links)
- Surveillance of systemic trafficking of macrophages induced by UHMWPE particles in nude mice by noninvasive imaging (Q34116545) (← links)
- IL-2: the first effective immunotherapy for human cancer. (Q34423519) (← links)
- Lysis of primary hepatic tumours by lymphokine activated killer cells (Q34527814) (← links)
- Fate of intravenously administered rat lymphokine-activated killer cells labeled with different markers (Q34573594) (← links)
- Influence of tumour physico-chemical conditions on interleukin-2-stimulated lymphocyte proliferation (Q35993205) (← links)
- Clearance rates and systemic effects of intravenously administered interleukin 2 (IL-2) containing preparations in human subjects (Q36047402) (← links)
- Transforming growth factor beta 1 (TGF-beta 1) produced in tumour tissue after chemotherapy acts as a lymphokine-activated killer attractant (Q36135517) (← links)
- Human T-cell growth factor: partial amino acid sequence, cDNA cloning, and organization and expression in normal and leukemic cells (Q36258122) (← links)
- Continuous infusion of recombinant interleukin-2 with or without autologous lymphokine activated killer cells for the treatment of advanced renal cell carcinoma (Q36307569) (← links)
- Regression of a disseminated syngeneic solid tumor by systemic transfer of lymphoid cells expanded in interleukin 2 (Q36346766) (← links)
- Successful immunotherapy of natural killer-resistant established pulmonary melanoma metastases by the intravenous adoptive transfer of syngeneic lymphocytes activated in vitro by interleukin 2 (Q36348452) (← links)
- Therapy of disseminated murine leukemia with cyclophosphamide and immune Lyt-1+,2- T cells. Tumor eradication does not require participation of cytotoxic T cells (Q36350025) (← links)
- Antigen-driven long term-cultured T cells proliferate in vivo, distribute widely, mediate specific tumor therapy, and persist long-term as functional memory T cells (Q36351792) (← links)
- Autologous tumor-specific cytotoxic T lymphocytes in the infiltrate of human metastatic melanomas. Activation by interleukin 2 and autologous tumor cells, and involvement of the T cell receptor (Q36355478) (← links)
- Delivery of methoxymorpholinyl doxorubicin by interleukin 2-activated NK cells: effect in mice bearing hepatic metastases (Q36617600) (← links)
- Cytokine-induced killer cells promote antitumor immunity (Q36741617) (← links)
- Systemic trafficking of macrophages induced by bone cement particles in nude mice (Q36980386) (← links)
- HLA identical leukemia cells and T cell growth factor activate cytotoxic T cell recognition of minor locus histocompatibility antigens in vitro (Q36990228) (← links)
- Transfer of murine host protection by using interleukin-2-dependent T-lymphocyte lines. (Q36998536) (← links)
- Immunotherapy for liver tumors: present status and future prospects. (Q37144014) (← links)
- Promoting transplantation tolerance; adoptive regulatory T cell therapy (Q38097917) (← links)
- Lymphokine activated killer cells (Q38694439) (← links)
- Dual reporter gene imaging for tracking macrophage migration using the human sodium iodide symporter and an enhanced firefly luciferase in a murine inflammation model (Q39151440) (← links)
- The development of new immunotherapies for the treatment of cancer using interleukin-2. A review (Q39512710) (← links)
- Assessment of the number of local cytotoxic T lymphocytes required for degradation of micrometer-size tumor spheroids (Q39918449) (← links)
- Interleukin-2 and interferon in renal cell carcinoma. (Q40384693) (← links)
- Transcatheter arterial injection of autologous lymphokine-activated killer (LAK) cells into patients with liver cancers (Q40762779) (← links)
- A phase-II study of low-dose cyclophosphamide and recombinant human interleukin-2 in metastatic renal cell carcinoma and malignant melanoma (Q40779138) (← links)
- Tumour infiltrating lymphocytes: insights into tumour immunology and potential therapeutic implications (Q40849487) (← links)
- Unprimed CD4+ and CD8+ T cells can be rapidly activated by a CD3 x CD19 bispecific antibody to proliferate and become cytotoxic (Q41011863) (← links)
- Induction of specific cytotoxic T lymphocytes against autologous brain tumor by crossreactive allo-tumor cell stimulation (Q41122172) (← links)
- T cell clones and their products: experimental clues for the immunoprophylaxis and immunotherapy of intracellular bacterial infections? (Q41407258) (← links)
- Specific adoptive immunotherapy of malignant glioma with long-term cytotoxic T lymphocyte line expanded in T-cell growth factor. Experimental study and future prospects (Q41435191) (← links)
- Antitumour efficacy of lymphokine-activated killer cells loaded with ricin against experimentally induced lung metastases (Q41645609) (← links)
- In vivo effector function of influenza virus-specific cytotoxic T lymphocyte clones is highly specific (Q42937027) (← links)
- Confusion about the tissue distribution of lymphokine-activated killer (LAK) cells (Q43742600) (← links)
- Lymphokine-activated killer (LAK) cells modulate the effects of IL-2 on a T cell-mediated immune response (Q44499384) (← links)
- Immunotherapy of solid tumor by intratumoral infusion of lymphokine-activated killer cells (Q46441492) (← links)
- IL-2 and Beyond in Cancer Immunotherapy (Q50004232) (← links)
- Assessment of in vivo natural antitumor resistance and lymphocyte. Migration in mice: comparison of 125I-iododeoxyuridine with 111indium-oxine and 51chromium as cell labels. (Q54506080) (← links)
- Prospects of IL-2 in Cancer Immunotherapy. (Q55100965) (← links)
- Characterization of transendothelial migratory lymphokine-activated killer cells. (Q55284863) (← links)
- Reconstitution of anti-tumor effects of lentinan in nude mice: roles of delayed-type hypersensitivity reaction triggered by CD4-positive T cell clone in the infiltration of effector cells into tumor. (Q55467657) (← links)
- T cell clones and their products: Experimental clues for the immunoprophylaxis and immunotherapy of intracellular bacterial infections? (Q57599095) (← links)
- Interactions between interleukin-2-activated lymphocytes and vascular endothelium: binding to and migration across specialized and non-specialized endothelia (Q67906485) (← links)